<ARTICLE> 5 <LEGEND> Exhibit 27 for Bristol-Myers Squibb Company for the period ended 6/30/99 <MULTIPLIER> 1000000 <PERIOD-TYPE> 6-MOS <FISCAL-YEAR-END> DEC-31-1999 <F1> <PERIOD-END> JUN-30-1999 <CASH> 2081 <SECURITIES> 267 <RECEIVABLES> 3218 <F2> <ALLOWANCES> 0 <INVENTORY> 2044 <CURRENT-ASSETS> 8658 <PP&E> 7613 <DEPRECIATION> 3158 <TOTAL-ASSETS> 16214 <CURRENT-LIABILITIES> 5367 <BONDS> 1327 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 219 <OTHER-SE> 7841 <TOTAL-LIABILITY-AND-EQUITY> 16214 <SALES> 9774 <TOTAL-REVENUES> 9774 <CGS> 2666 <TOTAL-COSTS> 2666 <OTHER-EXPENSES> 2071 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 64 <INCOME-PRETAX> 2794 <INCOME-TAX> 775 <INCOME-CONTINUING> 2019 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 2019 <EPS-BASIC> 1.02 <EPS-DILUTED> 1.00 <FN> <F1> Items reported as "zero" are not applicable or are immaterial to the consolidated financial position of the Company. <F2> Receivables are reported net of allowances for doubtful accounts.